Top 5 Bank Stocks To Own For 2018

5 Peeks at a Hot New Variable Annuity Guarantee Paper

Transamerica to Outsource Life, Voluntary Benefits and Annuity Administration

Taxpayer Advocate Blasts ‘Unreal’ IRS Audits

The U.S. tax overhaul cost JPMorgan Chase & Co. $2.4 billion last year. Consider it a down payment on a more profitable future.

The bank said that while it took accounting charges in the fourth quarter tied mostly to levies on foreign earnings required under the new law, its effective tax rate will drop this year to 19 percent from 32 percent. That means that if JPMorgan generates the same pretax profit this year as it did in 2017, earnings will balloon by more than $3.5 billion.

JPMorgan is the first big U.S. bank to detail the windfall the industry will receive under the new tax regime, which was signed into law last month. Discussion about the ramifications of the changes is likely to dominate earnings season over the firms’ quarterly results.

Chief Financial Officer Marianne Lake has said that some of those gains will probably evaporate as banks compete with one another on pricing and services.

Top 5 Bank Stocks To Own For 2018: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Chris Lange]

    Conn’s Inc. (NASDAQ: CONN) will share its latest quarterly earnings on Thursday. The consensus estimates call for a net loss of $0.07 per share and $413.12 million in revenue. Shares were at $6.84 on Fridays close, in a 52-week range of $6.54 to $34.60. The consensus price target is $13.17.

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Lisa Levin]

    Conn's Inc (NASDAQ: CONN) shares were also up, gaining 32 percent to $11.18 after the company reported better-than-expected earnings for its fourth quarter.

Top 5 Bank Stocks To Own For 2018: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:


    For the details of Novo A’s stock buys and sells, go to

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

Top 5 Bank Stocks To Own For 2018: Insignia Systems, Inc.(ISIG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Insignia Systems, Inc. (NASDAQ: ISIG) were down 18 percent to $1.45. Insignia Systems announced a 2.313 million share common stock offering via selling holders.

  • [By Lisa Levin]

    Shares of Insignia Systems, Inc. (NASDAQ: ISIG) were down 20 percent to $1.41. Insignia Systems announced a 2.313 million share common stock offering via selling holders.

Top 5 Bank Stocks To Own For 2018: Fiat Chrysler Automobiles N.V.(FCAU)

Advisors’ Opinion:

  • [By ]

    Specifically, companies like Fiat Chrysler Automobiles (FCAU) , GM and Ford manufacturer the vehicles, but then franchised distributors (i.e., dealerships) are the ones who sell them to the consumer. These dealerships allow for test drives and services centers as well.

  • [By Douglas A. McIntyre]

    Other top manufacturers are also expected to have a rough month. However, Fiat Chrysler AutomobilesN.V. (NYSE: FCAU) is not among them. Its sales are expected to fall only 0.7% to 175,000. Kelley Blue Book Executive Analyst Rebecca Lindland said:

  • [By Paul Ausick]

    Source: courtesy of Fiat Chrysler AutomobilesFiat Chrysler Automobiles NV (NYSE: FCAU) reports monthly U.S. sales figures on six brands. In August five of those posted year-over-year sales declines

  • [By Benzinga News Desk]

    President Trump’s Department of Justice gave its expert witness a second chance on Tuesday to make a convincing case against AT&T’s (NYSE: T) proposed $85 billion buyout of CNN-owner Time Warner (NYSE: TWX): Link

    US MBA mortgage applications w.e. 20 April -0.2% vs +4.9% prior
    The Energy Information Administration’s weekly report on petroleum inventories in the U.S. will be released at 10:30 a.m. ET.
    The Treasury is set to auction 5-year notes at 1:00 p.m. ET.
    BMO upgraded Disney (NYSE: DIS) from Underperform to Market Perform
    Stifel upgraded Alphabet (NASDAQ: GOOGL) from Hold to Buy
    Jefferies downgraded Fiat Chrysler (NYSE: FCAU) from Buy to Hold
    Stifel downgraded Floor & Decor (NYSE: FND) from Buy to Hold

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Daniel Miller]

    This isn’t a new trend; sales of new cars are on pace to decline for the fifth straight year, and Detroit’s two largest automakers are reportedly taking action. Per a report from The Wall Street Journal, GM plans to stop production of the Chevrolet Sonic as early as this year as well as the Chevrolet Impala over the next few years. GM’s crosstown rival, Ford, is planning similar moves and will stop producing the Fiesta for the U.S. market as soon as 2019, and will also chop the Taurus — a nameplate that was once Ford’s flagship sedan in the U.S. market. These moves have been considered for some time; Fiat Chrysler Automobiles (NYSE:FCAU) already axed the Dodge Dart and Chrysler 200 from its U.S. portfolio, so it could push all-in on more profitable Ram Truck and Jeep brand sales, which are far more lucrative.

  • [By John Rosevear]

    For months, Trump has used tweetsto harangue U.S. manufacturers building factories outside of the country and pressure them to invest in U.S. plants instead. Earlier this month, Ford Motor Company (NYSE:F) and Fiat Chrysler Automobiles (NYSE:FCAU) both announced significant investments in U.S. factories. Ford also announced the cancellation of a plan to build a new factory in Mexico, which was well received among Trump supporters.

Top 5 Bank Stocks To Own For 2018: Insmed, Inc.(INSM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Insmed Incorporated (NASDAQ: INSM) shares shot up 113 percent to $26.15 following the announcement of positive top-line results from its Phase 3 Convert study of ALIS in adult patients with treatment-refractory nontuberculous Mycobacterial (NTM) lung disease..

  • [By Max Byerly]

    TRADEMARK VIOLATION WARNING: “TIAA CREF Investment Management LLC Buys 13,438 Shares of Insmed, Inc. (INSM)” was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at

  • [By Jon C. Ogg]

    Insmed Inc. (NASDAQ: INSM) was raised to Outperform from Neutral at Credit Suisse.

    Lululemon Athletica Inc. (NASDAQ: LULU) was downgraded to Hold from Buy at Needham, based on the run-up in shares and on a harder earnings comparison that will be harder to beat. Lululemon was up 1% at $96.31 but was down 2% at $94.30 on Monday. It had a consensus target price of $89.93.

  • [By Lisa Levin]

    Insmed Incorporated (NASDAQ: INSM) shares were also up, gaining 10 percent to $25.72. Credit Suisse upgraded Insmed from Neutral to Outperform.

    Equities Trading DOWN

  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 78.82 percent to close at $7.26 on Monday.
    GEE Group, Inc. (NYSE: JOB) shares jumped 18 percent to close at $2.36.
    McDermott International, Inc. (NYSE: MDR) climbed 15.7 percent to close at $7.00 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) gained 17.21 percent to close at $3.61.
    Stars Group Inc. (NASDAQ: TSG) rose 14.16 percent to close at $33.45. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares jumped 12.79 percent to close at $25.58.
    Nautilus, Inc. (NYSE: NLS) shares gained 11.52 percent to close at $15.00. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    Box, Inc. (NYSE: BOX) rose 10.94 percent to close at $22.91.
    Insmed Incorporated (NASDAQ: INSM) shares rose 10.76 percent to close at $26.05. Credit Suisse upgraded Insmed from Neutral to Outperform.
    NextDecade Corporation (NASDAQ: NEXT) shares rose 10.02 percent to close at $6.48.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) shares gained 8.37 percent to close at $2.46 on Monday after falling 10.98 percent on Friday.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares gained 7.81 percent to close at $11.11.
    Vectren Corporation (NYSE: VVC) shares rose 7.26 percent to close at $70.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Tennant Company (NYSE: TNC) rose 6.66 percent to close at $74.45 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Hanesbrands Inc.